Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0461929603
Mon, 05.05.2025
Xlife Sciences AG
Zurich, 5th of May 2025: Xlife Sciences AG («Xlife Sciences»; SIX: XLS) today published its 2024 Valuation Report, evaluating the company’s project portfolio as of December 31, 2024.
The independent consulting firm CYLAD Consulting conducted the assessment, which covers 16 project companies within Xlife Sciences’ total portfolio1. CYLAD Consulting [ … ]
Fri, 25.04.2025
Xlife Sciences AG
Zurich, 25th of April 2025: Xlife Sciences AG ("Xlife Sciences", SIX: XLS) today published its 2024 Annual Report. The past fiscal year was marked by strategically significant partnerships and technological breakthroughs within its portfolio companies.
«2024 was a successful year for Xlife Sciences in terms of technological progress within our port [ … ]
Wed, 23.04.2025
Xlife Sciences AG
The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.
Zurich, 23rd of April 2025: Xlife Sciences AG («Xlife Sciences»; SIX:XLS), a leader for value development and commercialization of early-stage research projects, announces that its [ … ]